Call for proposals on the European Hub for vaccine development (HERA) – CP-g-24-10
Summary
The Programme aims to improve and promote health in the Union to reduce the burden of communicable and non-communicable diseases by:
- protecting people from serious cross-border health threats
- improving the availability, accessibility and affordability of medicines, medical devices and other crisis-related products in the EU
- strengthening national health systems
Programme Name
Programme Description
The Programme aims to improve and promote health in the Union to reduce the burden of communicable and non-communicable diseases by:
- protecting people from serious cross-border health threats
- improving the availability, accessibility and affordability of medicines, medical devices and other crisis-related products in the EU
- strengthening national health systems
Call
Detailed Call Description
This action supports the policy priority to enhance crisis preparedness and response for future health emergencies in relation to medical countermeasures, with a focus on priority pathogens with pandemic potential.
The Hub will develop a strategic vaccine plan for Europe, and subsequently deliver on creating vaccine prototypes in particular for priority pathogens with epidemic and pandemic potential, further developing of state-of-the-art technologies that can be rapidly adapted, preparing relevant master clinical trial protocols, combining its activities to reach out to clinical trial capacities/networks and at scale production initiatives at national and European levels. The Hub should establish connections with private manufacturers including through specific manufacturing agreements such as EUFAB or comparable national models.
Financing percentage by EU or other bodies / Level of Subsidy or Loan
60%
You can apply for a higher project funding rate (80%) if your project is of ‘exceptional utility’ (further details in the call document p.32).
Indicative project budget: €102.000.000
Eligibility For Participation Notes
In order to be eligible, the applicants (beneficiaries and affiliated entities) must:
- be legal entities (public or private bodies)
- be established in one of the eligible countries, i.e.:
- EU Member States (including overseas countries and territories (OCTs)
- eligible non-EU countries:
- listed EEA countries and countries associated to the EU4Health Programme (list of participating countries)
This call targets consortia of developers of vaccines covering expertise in development including publicly funded and industrial organisations.
Programme Category
EU Competitive ProgrammesTotal Budget
€102.000.000Thematic Categories
- Health
- Research, Technological Development and Innovation
Eligibility for Participation
- Businesses
- International Organisations
- Legal Entities
- Private Bodies
- Researchers/Research Centers/Institutions
- State-owned Enterprises
Call Opening Date
23/05/2024Call Closing Date
05/09/2024National Contact Point(s)
Ministry of Health, Department of European Affairs
Ms MAKRIGIORGI Elena
Email: emakrigiorgi@moh.gov.cy
EU Contact Point
For help related to this call, please contact: HaDEA-HP-CALLS@ec.europa.eu